Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 24, 2009, Pages 2451-2456

  Bobin Dubigeon, C ^a,b   Amiand, M B ^a   Herrenknecht, C ^b   Bard, J M ^a,b  

^a CLCC René Gauducheau ^*  (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Liquid chromatography mass spectrometry; Pemetrexed; Pharmacokinetic studies; Plasma

Indexed keywords

ANALYTICAL COLUMNS; DRUG MONITORING; HUMAN PLASMAS; ISOCRATIC; LINEAR RANGE; LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; LOWER LIMIT OF DETECTIONS; MOBILE PHASE; PEMETREXED; PHARMACOKINETIC STUDIES; QUADRUPOLE;

CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; PATIENT MONITORING; PHARMACOKINETICS; PLASMA (HUMAN);

PLASMAS;

ACETONITRILE; FORMIC ACID; PEMETREXED;

ACCURACY; ARTICLE; BLOOD SAMPLING; CHEMICAL STRUCTURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; VALIDATION STUDY;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; GLUTAMATES; GUANINE; HUMANS; MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY;

EID: 67651014960     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.06.020     Document Type: Article

References (20)

1. Goldman D., and Zhao R. Semin. Oncol. 29 (2002) 3
2. Lansiaux A., and Lokiec F. Bull. Cancer 94 (2007) 134
3. Bunn P.A., and Smith I.E. Semin. Oncol. 20 (2002) 1
4. EMEA (2004) http://www.emea.europa.eu/humandocs/PDFs/EPAR/alimta/102004en1.pdf.
5. Hughes A., Calvert P., Azzabi A., Plummer R., Johnson R., Rusthoven J., Griffin M., Fishwick K., Boddy A.V., Verrill M., and Calvert H. J. Clin. Oncol. 20 (2002) 3533
6. Scagliotti G.V., Shin D.M., Kindler H.L., Vasconcelles M.J., Keppler U., Manegold C., Burris H., Gatzemeier U., Blatter J., Symanowski J.T., and Rusthoven J.J. J. Clin. Oncol. 21 (2003) 1556
7. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., Niyikiza C., and Paoletti P. J. Clin. Oncol. 21 (2003) 2636
8. Li K.M., Rivory L.P., and Clarke S.J. Br. J. Cancer 22 (2007) 1071
9. Ouellet D., Periclou A.P., Johnson R.D., Woodworth J.R., and Lalonde R.L. Cancer Chemother. Pharmacol. 46 (2000) 227
10. Latz J.E., Chaudhary A., Ghosh A., and Johnson R.D. Cancer Chemother. Pharmacol. 57 (2006) 401
11. Woodland J.M., Barnett C.J., Dorman D.E., Gruber J.M., Shih C., Spangle L.A., Wilson T.M., and Ehlhardt W.J. Drug Metab. Dispos. 25 (1997) 693
12. Hamilton C.L., and Kirkwood J.A. J. Chromatogr. B Biomed. Appl. 654 (1994) 297
13. Rinaldi D.A., Burris H.A., Dorr F.A., Woodworth J.R., Kuhn J.G., Eckardt J.R., Rodriguez G., Corso S.W., Fields S.M., Langley C., et al. J. Clin. Oncol. 13 (1995) 2842
14. Rivory L.P., Clarke S.J., Boyer M., and Bishop J.F. J. Chromatogr. B 765 (2001) 135
15. Chaudhary A.K., Schannen V., and Knadler M.P. Presented at the Proceedings of 47th ASMS Conference on Mass Spectrometry and Allied Topics. Dallas, TX, June 13-17 (1999) (abstract)
16. Widemann B.C., Sung E., Anderson L., Salzer W.L., Balis F.M., Monitjo K.S., McCully C., Hawkins M., and Adamson P.C. J. Pharmacol. Exp. Ther. 294 (2000) 894
17. Nowatzke W., and Woolf E. AAPS J. 20 (2007) E117
18. Guidance for Industry Bioanalytical Method Validation from FDA (2001), US Department of Health and Human Services, Food and Drug Administration, CDER, Rockville, USA
19. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., et al. STP Pharm. Pract. 7 (1997) 169
20. Zhang Y., and Trissel L.A. Ann. Pharmacother. 40 (2006) 1082